Your browser doesn't support javascript.
loading
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
Serrano, Davide; Gandini, Sara; Thomas, Parjhitham; Crew, Katherine D; Kumar, Nagi B; Vornik, Lana A; Lee, J Jack; Veronesi, Paolo; Viale, Giuseppe; Guerrieri-Gonzaga, Aliana; Lazzeroni, Matteo; Johansson, Harriet; D'Amico, Mauro; Guasone, Flavio; Spinaci, Stefano; Bertelsen, Bjørn-Erik; Mellgren, Gunnar; Bedrosian, Isabelle; Weber, Diane; Castile, Tawana; Dimond, Eileen; Heckman-Stoddard, Brandy M; Szabo, Eva; Brown, Powel H; DeCensi, Andrea; Bonanni, Bernardo.
Afiliación
  • Serrano D; European Institute of Oncology IRCCS, Milan, Italy.
  • Gandini S; European Institute of Oncology IRCCS, Milan, Italy.
  • Thomas P; The University of Texas MD Anderson Cancer Center, Houston.
  • Crew KD; Columbia University Irving Medical Center, New York, New York.
  • Kumar NB; Moffitt Cancer Center, University of South Florida, Tampa.
  • Vornik LA; The University of Texas MD Anderson Cancer Center, Houston.
  • Lee JJ; The University of Texas MD Anderson Cancer Center, Houston.
  • Veronesi P; European Institute of Oncology IRCCS, Milan, Italy.
  • Viale G; European Institute of Oncology IRCCS, Milan, Italy.
  • Guerrieri-Gonzaga A; European Institute of Oncology IRCCS, Milan, Italy.
  • Lazzeroni M; European Institute of Oncology IRCCS, Milan, Italy.
  • Johansson H; European Institute of Oncology IRCCS, Milan, Italy.
  • D'Amico M; Ospedali Galliera, Genoa, Italy.
  • Guasone F; Ospedale Villa Scassi ASL3, Genoa, Italy.
  • Spinaci S; Ospedale Villa Scassi ASL3, Genoa, Italy.
  • Bertelsen BE; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
  • Mellgren G; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.
  • Bedrosian I; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Weber D; The University of Texas MD Anderson Cancer Center, Houston.
  • Castile T; The University of Texas MD Anderson Cancer Center, Houston.
  • Dimond E; The University of Texas MD Anderson Cancer Center, Houston.
  • Heckman-Stoddard BM; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Brown PH; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • DeCensi A; The University of Texas MD Anderson Cancer Center, Houston.
  • Bonanni B; Ospedali Galliera, Genoa, Italy.
JAMA Oncol ; 9(5): 664-672, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36951827
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia